S. John Weroha
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 30
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 6
- Oncology top 5%
- PARP inhibition in cancer therapy 10
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 7
-
- Growth Hormone and Insulin-like Growth Factors 7
-
- Advanced Breast Cancer Therapies 6
-
- Epigenetics and DNA Methylation 6
- CRISPR and Genetic Engineering 5
- Co-authors
- Paul HaluskaXiaonan HouSara Antonia LiJonathan J. LiWilma L. LingleAnn L. ObergMarc A. BeckerJeffrey L. Salisbury
- Partner nations
- United StatesItalySpain
In The Last Decade
S. John Weroha
66 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 93
- Reproductive Medicine 276
- Cancer Research 368
- Oncology 610
- Obstetrics and Gynecology 96
- Endocrinology, Diabetes and Metabolism 200
Countries citing papers authored by S. John Weroha
This map shows the geographic impact of S. John Weroha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. John Weroha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. John Weroha more than expected).
Fields of papers citing papers by S. John Weroha
This network shows the impact of papers produced by S. John Weroha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. John Weroha. The network helps show where S. John Weroha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. John Weroha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 36 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 0 | |
| 12 | 2020 | 48 | |
| 13 | 2020 | 76 | |
| 14 | 2020 | 17 | |
| 15 | 2019 | 45 | |
| 16 | 2018 | 2 | |
| 17 | Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance | 2018 | 1 |
| 18 | 2017 | 47 | |
| 19 | 2013 | 7 | |
| 20 | 2012 | 28 |
About S. John Weroha
S. John Weroha is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (30 papers), PARP inhibition in cancer therapy (10 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Endometrial and Cervical Cancer Treatments (7 papers), Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (6 papers), Epigenetics and DNA Methylation (6 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Reproductive Medicine (276 citations), Cancer Research (368 citations), Oncology (610 citations), Obstetrics and Gynecology (96 citations) and Endocrinology, Diabetes and Metabolism (200 citations). S. John Weroha has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Paul Haluska, Xiaonan Hou, Sara Antonia Li, Jonathan J. Li, Wilma L. Lingle, Ann L. Oberg, Marc A. Becker, Jeffrey L. Salisbury, Sean C. Harrington and Ossama Tawfik. Their work appears in journals such as Gynecologic Oncology, Cancer Research, PLoS ONE, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.